a:5:{s:8:"template";s:12036:" {{ keyword }}
{{ text }}
";s:4:"text";s:25683:"2010;363:2320–31. Cocaine. Int J Clin Pharmacol Biopharm. The views expressed in this article are those of the authors, and not necessarily those of the Department of Health and Human Services or its divisions, the Office of the Assistant Secretary for Health and the National Institute on Drug Abuse. Next steps . Background and objectives: The increase in neonatal abstinence syndrome (NAS) has underscored the need for NAS surveillance programs, but many rely on passive surveillance using unverified diagnosis codes. 2016;375:2468–79. J Addict Med. Assessment & Documentation. 2019;143:e20174183. As the foundational step of an overarching RAM focusing on the clinical definition of NAS, the findings from this RAM literature review of comparative clinical studies will inform broader discussions on challenges with existing methods used to define NAS and important inconsistencies and gaps that need to be addressed. Utilizing the results of the environmental scan to inform and tailor subsequent review of the literature, the scope of the search strategy was subsequently narrowed to specifically identify abstracts containing criteria used in the definition or description of NAS. Importantly, scoring assessments may also be influenced by inter-rater variability and are inherently subjective [17]. Addressing the current gap in knowledge and providing a standard clinical definition for NAS would lay the foundation for informing public health policy; improve the accuracy and reproducibility of NAS surveillance, administrative claims, clinical records and scientific reports; and can enhance needs assessment and care for mother–infant dyads affected by opioid exposure in the short and long term. J Perinatol (2021). In September 2019, an environmental scan using these keywords was carried out to gain insight on the breadth of literature in this subject area. et al. Some babies need extra loving, including those born with neonatal abstinence syndrome (NAS) which is similar to medicine or drug withdrawal in adults. 3). Neonatal Abstinence Syndrome. Abstracts were categorized by study comparison groups to facilitate a more structured review process. While 74% (42/57) of studies identified by this review included opioid exposure as an integral part of their participant eligibility and/or inclusion criteria for mothers, infants, and/or the mother–infant dyad, 26% (15/57) did not. In addition, a recent review examining NAS clinical and surveillance definitions at the state level revealed that only 3 of the 44 states participating in NAS-related data activities had both a specified clinical and surveillance definition in place [21]. Il survient lorsque, à la naissance, le bébé est soudainement privé des médicaments ou des drogues qui se trouvaient dans le corps de sa mère. 2018;141:e20173520. Pediatrics. Polysubstance use is common among those who use opioids. PubMed Google Scholar. The majority of studies in group 1 (64%; 9/14) did not include opioid exposure for mother or infant as part of their inclusion criteria. J Addict Med. Although this preliminary scan yielded a high volume of abstracts (n = 2817; data not shown), there was lower specificity for the primary research question (identifying specific criteria used to define NAS). The rising incidence of NAS has prompted an increased need for accurate research and public health data. Information and translations of neonatal abstinence syndrome in the most comprehensive dictionary definitions resource on the web. McQueen K, Murphy -Oikonen J. Neonatal abstinence syndrome. This is a happy time for you, but all parents face challenges in their baby’s first year. Neonatal abstinence syndrome after methadone or buprenorphine exposure. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and … Five articles were removed from group 2 that also represented secondary analyses stemming from the MOTHER trial. Reprinted with permission from Treatment of Opioid Dependence in Pregnancy: Vermont Guidelines. Guidelines for the identification and management of substance use and substance use disorders in pregnancy. Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancyWithdrawal or abstinence symptoms develop shortly after birth. Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women - No Study Results Posted. To ensure fidelity, an internal review was developed wherein a single reviewer independently examined recommendations for inclusion/removal of abstracts and articles. Rather, these terms were not distinctly specified in the keyword search. J Perinat Neonatal Nurs. MMWR Morb Mortal WklyRep. Three of the 4 (75%) studies in group 4 included opioid exposure in their participant inclusion criteria. Upstream of case reporting, the definition of NAS can vary significantly among providers and researchers. Overall, 57 articles (published from 1986 to 2019) adhered to the inclusion criteria for this literature review and were assessed for methodology used to define NAS (Fig. 2019;13:90–2. Abstinence syndrome (withdrawal) experienced following variable length of repeated exposure. Although NAS scoring and assessment tools (along with the requirement for pharmacologic treatment if scores were high enough) were not the main focus of this literature search, a majority of studies described these items as key criteria used to define NAS. 1975;12:19–32. Age-adjusted rate of drug … Se développent chez 55-94% des nouveaux nés exposés aux opiacés: 42- 94% d’entre eux auront besoin de pharmacotherapie. More than 45 years have elapsed since the seminal work describing neonatal abstinence syndrome (NAS) as a disorder in infants due to withdrawal from opioids and other substances after in utero exposures [1]. Although opium use dates back to the ancient civilizations of Mesopotamia (3400 BCE), the first surviving records of opium addiction date from the end of the 18th century.1 Morphine was isolated in 1804, heroin was synthesized in 1874, and addiction to these opioids became more common after their commercial production.2 An increase in the incidence of morphine and heroin addiction among women was noted as early as the 19th century3; however, infants were not thought to be affected because it was believed tha… Santa Monica: RAND Corporation; 2001. • According to hospital discharge data, during 2010 to 2018 in Delaware, 1,956 cases of NAS were identified with an incidence of 20.1 cases per 1,000 births. It is important to note that the keyword “opioids” was utilized to retrieve any occurrence of opioids in combination with the described terms. Neonatal Abstinence Syndrome: A Guide for Families. This could have a significant impact on the accuracy and reproducibility of claims and/or scientific data, especially when using electronic medical record data. Final iterative review of the full set of 888 resulted in 2 additional abstracts advanced for full-text review. Exclusion criteria included case reports, descriptive studies, observational, and other studies not designed to investigate outcomes between two distinct comparison groups, as a preliminary screen to promote inclusion of scientifically and analytically rigorous reports. In classifying cases of NAS using ICD -10-CM codes, we recommend the following guidelines to promote consistency in reporting for coding infants with neonatal abstinence syndrome and/or . Google Scholar. Any of the adverse consequences in the newborn of exposure to addictive or dangerous intoxicants during fetal development. Of these methodologies, the modified Finnegan tool was cited most frequently to define NAS (37%) followed by ICD-9/10 coding (30%) and the Finnegan NAS scoring system (28%). J Perinat Neonatal Nurs. To examine how NAS has been defined in clinical studies of opioid-exposed mothers and infants, a review process was developed based on the RAND/UCLA Appropriateness Method, yielding 888 abstracts. Withdrawal or abstinence symptoms develop shortly after birth. The ESC (which has been proposed more recently) and Lipsitz assessment tools each represented only 5% of the total articles reviewed (note 3 abstracts used a combination of ≥2 tools). Congratulations on the birth of your new baby! For a NAS baby, this condition develops mainly from the prenatal use of opioids like OxyContin and heroin, but it can also occur from their mother’s use of antidepressants like Zoloft or benzodiazepines like Xanax. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. Based on these two guideline documents, the EP generated a broad keyword search with the following terms: NAS and NOWS, clinical signs/symptoms/diagnosis, opioids, specific types of opioids (e.g., buprenorphine, methadone, morphine, fentanyl, oxycodone, heroin), infant/newborn, withdrawal, urine/meconium/umbilical cord/hair, and the most common assessment tools, such as: (1) the Finnegan NAS scoring system, (2) modified versions of the Finnegan, (3) the Eat, Sleep, Console (ESC) assessment tool, and (4) the Lipsitz Neonatal Drug Withdrawal Scoring System. Collectively, 55 categorized abstracts were identified as adhering to inclusion criteria for this literature review. Sixty-three abstracts were advanced for full-text review. In December 2019, a search was run in PubMed, Embase, Cochrane, and CINAHL. https://doi.org/10.1038/s41372-020-00893-8, DOI: https://doi.org/10.1038/s41372-020-00893-8, Journal of Perinatology 2). ΔDenotes studies citing two different methods to define NAS. Am J Public Health. Without evidence-based criteria or consensus guidelines on how to clinically define NAS, guidance that standardizes the clinical diagnosis is urgently needed. However, both approaches present significant challenges. Incidence of Neonatal Abstinence Syndrome 25 States, 2012–2013 Ko JY, Patrick SW, Tong VT, et al. Neonatal laboratory results, maternal laboratory results and maternal history will be used to inform clinical decision -making. Finnegan LP, Kron RE, Connaughton JF, Emich JP. A diagnosis of NAS in an infant who does not meet criteria for medication to alleviate symptoms may allow the application of targeted non-pharmacologic therapies to address NAS-related difficulties. In 2019, the Council of State and Territorial Epidemiologists (CSTE) developed a NAS case definition to standardize surveillance measures throughout different jurisdictions (local and state) across the U.S. [4]. J Perinatol (2021), 10.1038/s41372-020-00893-8. This expert literature review illustrates specific methodologies most frequently cited to define NAS in clinical studies of mothers, infants, and mother–infant dyads. This RAM literature review was carried out between September 2019 and June 2020. While each of these articles had a distinct focus, they originated from the same dataset using the same clinical definition of NAS. Studies within each category were then reviewed for consideration of opioid exposure of mother and/or infant as part of participant eligibility and/or inclusion criteria. For group 4, 2 articles examined sex differences in infants diagnosed with NAS, 1 examined allelic differences and NAS outcomes, and 1 study investigated NAS in preterm vs term infants. Specific consideration was given as to whether individual trials included opioid exposure as a crucial component of the study’s inclusion criteria for defining NAS (Fig. Caring for your new baby during withdrawal. The key objective of this RAM literature review was to identify criteria described in clinical studies to define NAS. Often heterogeneously defined [9], NAS can connote opioid-exposed infants and/or exposure to other substances, demonstration of withdrawal signs/symptoms, and/or receiving pharmacotherapy for withdrawal. Common sources of in utero exposure are prescription and non- Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome. The administrative methods used were International Classification of Diseases, Ninth and Tenth Revision (ICD-9/10) codes and the clinical methods used were the Finnegan NAS scoring system, modified versions of the Finnegan, ESC, and Lipsitz. These studies collectively examined neonatal outcomes in the setting of different treatment options for NAS, including supportive non-pharmacologic and pharmacotherapeutic approaches. Assessment and treatment of abstinence in the infant of the drug-dependent mother. Neonatal abstinence syndrome is influenced by many factors, including maternal-fetal-placental pharmacokinetics, neurotransmitter dysregulation, genetic and epigenetic factors. Pediatr Clin N. Am. Coyle MG, Brogly SB, Ahmed MS, Patrick SW, Jones HE. Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancyWithdrawal or abstinence symptoms develop shortly after birth. Neonatal abstinence syndrome is a potentially preventable problem. Standardization of state definitions for neonatal abstinence syndrome surveillance and the opioid crisis. Amphetamine and derivatives. Neonatal abstinence syndrome (NAS) results from discontinuation of in utero exposures to opioids/substances. Independent review led to complete agreement with respect to key characteristics identified in each study. The work group developed a template for members to consider as they develop their policy and procedures. ; The core consideration for criteria would be grounded in the infant’s clinical signs of withdrawal independent of the need for pharmacologic treatment. 2019;66:353–67. Most articles included in our review fell into 3 different categories of participant comparison groups: (1) NAS vs control, (2) maternal exposure type, (3) infant treatment type, and a fourth “other” category of articles that did not sort into groups 1–3. Specific search terms included (1) NAS; (2) NOWS; (3) urine, umbilical cord, and/or meconium and NAS or NOWS; and (4) criteria, criterion, definition, define, or diagnosis of NAS or NOWS. To obtain Define neonatal abstinence syndrome. Positive predictive value of administrative data for neonatal abstinence syndrome. Shahla M. Jilani. NAS may occur when a pregnant woman takes drugs such as heroin, codeine, oxycodone (Oxycontin), methadone, or buprenorphine. Historically, most clinical descriptions of NAS have included a constellation of signs and symptoms of withdrawal that may require pharmacologic intervention [5, 6]. The focused keyword search yielded 888 abstracts after which duplicates, poster abstracts, animal studies, review articles, gray literature (white papers, government and academic reports not published by commercial publishers), and foreign language papers were removed (Fig. neonatal abstinence syndrome: a behavioral pattern of irritability, tremulousness, and inconsolability exhibited in newborns exposed to heroin and methadone. CAS  Second, the use of medical claims data may reflect inter-coder differences in the assignment of diagnosis and billing codes for NAS. Of note, during the full-text review phase of this process (see below), no additional assessment tools were identified as in use for defining/diagnosing NAS or NOWS. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional. As a final measure of consistency, a confirmatory review of the full set of 888 abstracts was carried out as an iterative scan for abstracts eligible for inclusion; 2 additional abstracts were advanced for full-text review. Although most commonly conceptualized as withdrawal from opioids in exposed infants, other substance exposures and maternal/infant factors can affect NAS expression, further complicating criteria for a definition of NAS [8]. Thus this term was then removed in order to develop an appropriately focused keyword search. Geneva: WHO; 2014. For design of the initial keyword search, the World Health Organization Guidelines for the Identification and Management of Substance Use and Substance Use Disorders in Pregnancy and the American Academy of Pediatrics Clinical Report: Neonatal Drug Withdrawal were referenced [12, 13]. Amphetamine. Without it, incorrect use of the scoring tool may result in errors in treatment [19] and likewise could be similarly problematic for the linked question of NAS diagnosis. Studies within this collective group examined clinical, developmental, socioeconomic, demographic, and healthcare utilization characteristics between children diagnosed with NAS compared to those who were not. Prenatal opioid exposure, neonatal abstinence syndrome/neonatal opioid withdrawal syndrome, and later child development research: shortcomings and solutions. Most noteworthy, this key knowledge gap highlights the critical need for addressing the definition of NAS at a point fundamentally upstream of the use of a scoring tool or administrative coding—namely, at the bedside at a clinical diagnostic level. Nat Rev Dis Prim. 2016;65:799–802. These approaches highlight the need for a more refined and standardized definition of NAS. More comprehensive reviews have previously described limitations in NAS literature; more specifically, noting a predominance of uncontrolled and nonrandomized studies with lower generalizability [14]. the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in 2012;129:e540–60. Article  10 NAS and the Prescription Opioid Epidemic Rudd RA, Aleshire N, Zibbell JE, et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000–2009. It is noteworthy that the latter (studies not assessing distinct comparison groups) may offer descriptions of the NAS definition that could be contributory to this discussion. Jones HE, Kaltenbach K, Heil SH, et al. This method may also be subjective and not necessarily directly associated with the infant’s clinical presentation. Neonatal abstinence syndrome: presentation and treatment considerations. N. Engl J Med. Jilani, S.M., Jordan, C.J., Jansson, L.M. Abstracts were divided into these three structured categories for subsequent full-text review based on the rationale that these different study types/points of focus may preferentially involve one assessment tool over another (see “Results” below for more detail). While our approach carries the limitations of a non-systematic review, it offers a conceptual summary of the limited number of available randomized control and cohort trials and the criteria they used to investigate various key outcomes for the mother–infant dyad. Risks for developing NAS “Narcotics” Definition. in utero ISSN 1476-5543 (online), Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review, https://kansaspqc.org/wp-content/uploads/2019/06/Slides-Kasehagen-Jackson-Coding-NAS.pdf, http://creativecommons.org/licenses/by/4.0/, https://doi.org/10.1038/s41372-020-00893-8. Other substance exposures beyond opioid use can affect NAS expression, including the demonstration of withdrawal signs/symptoms and their severity and/or pharmacotherapy decisions for the infant. As an added measure to limit the effects of inter-reviewer variability, categorized abstracts selected by the FSC (n = 67) underwent a second review by the EP to reassess for adherence to inclusion criteria. The first step of the RAM process is a critical literature review, which is the focus of this article. Similarly, we set out to examine available literature in order to develop a synthesis of scientific evidence specific to this research question, distinct from statistical methods employed in meta-analyses. We would like to thank Nancy Terry and the research librarian team at the NIH library for conducting this comprehensive literature search and abstract/article retrieval. Neonatal Abstinence Syndrome Care is structured as follows: Chapter 1: Epidemiology & Pathophysiology Objectives (Key Takeaways) Overview Definition History Case Study Chapter 1 Quiz Chapter 2: Clinical Phenomenon Objectives (Key Takeaways) Clinical Phenomenon Clinical Factors Signs and Symptoms Other Clinical Factors When To Look Out for Signs of NAS Case Study Chapter 2 Quiz … 2017;11:178–90. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and gastrointestinal disturbances. A more liberal definition includes exposure to non- opioid substances; however, assessment tools for NAS were developed for infants exposed to opioids. While most cited opioid exposure as integral to their inclusion criteria, 26% did not. In the meantime, to ensure continued support, we are displaying the site without styles Preferred Label: neonatal abstinence syndrome; MeSH definition: Fetal and neonatal addiction and withdrawal as a result of the mother's dependence on drugs during pregnancy. An evidence table was constructed by abstracting pertinent information from the articles as a summary of findings from the full-text review. • Neonatal abstinence syndrome (NAS) is a withdrawal syndrome in newborns occurring after birth that is primarily caused by maternal opiate use during pregnancy. Neonatal abstinence syndrome (NAS) is a newborn syndrome comprised of a constellation of signs of in utero exposure to, and withdrawal from, one or more medications, drugs, and other substances known to cause withdrawal in adults (1-3). They underwent full-text review independently by two reviewers assessing two key characteristics: (1) method(s) that distinguished infants with a clinical diagnosis of NAS to those without and (2) opioid exposure for mother and infant. Definition of neonatal abstinence syndrome in the Definitions.net dictionary. A key next step to closing fundamental knowledge gaps will be to develop standard clinical criteria for the diagnosis of NAS that are both practical and broadly applicable to clinical practice. Symptoms exhibited are loud, high-pitched crying, sweating, yawning and … However, retrieved abstracts were not excluded if found to address the primary research question while including other substance exposure in the study design. Thank you for visiting nature.com. 203-213. JAMA. Of the evidence-based approaches available for assessing clinical validity and appropriateness, RAM is unique in offering the opportunity to leverage broad expert input to address key knowledge gaps in the literature [10]. Neonatal Abstinence Syndrome (414819007); Newborn drug withdrawal syndrome (414819007); Drug withdrawal syndrome in newborn (414819007); Neonatal withdrawal syndrome (414819007); Neonatal drug withdrawal syndrome (414819007); Neonatal abstinence syndrome (414819007) Monarch Initiative: MONDO:0005566: Definition. Pediatrics 2014;134:e547–61. McQueen K, Murphy-Oikonen JM. PCP. After a preliminary screen for candidate abstracts, the FSC recommended 67 abstracts for further review. N. Engl J Med. A Studies were evaluated for administrative vs clinical methodology cited to define NAS, described as: Administrative: International Classification of Diseases, Ninth or Tenth Revision (ICD-9/10), vs Clinical: the Finnegan NAS scoring system, modified versions of the Finnegan, Eat Sleep Console (ESC) and Lipsitz. Our objective was to evaluate how different definitions of NAS … It reinforces the importance of a standardized clinical definition for NAS as an essential step in advancing our discussions. Council of State and Territorial Epidemiologists. *Denotes e-publication (2019) ahead of print (2020) retrieved by search parameters run in December 2019. 2016;375(25):2468–2479; Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Am J Drug Alcohol Abuse, 8 (1981), pp. 2012;307:1934–40. Google Scholar. There is no gold standard definition for capturing NAS across clinical, research, and public health settings. Google Scholar. Journal of Perinatology NAS is most often caused when a woman takes drugs called opioids during pregnancy. https://medical-dictionary.thefreedictionary.com/neonatal+abstinence+syndrome. Article  Neonatal abstinence syndrome (NAS) results from discontinuation of in utero exposures to opioids/substances. This is crucial not only for clinical trials of new and existing therapeutics but also for improving downstream needs assessment and care for the appropriately identified mother–infant dyad. Per inclusion criteria, 57 abstracts underwent full-text review. The consequences include, but are not limited to, preterm delivery, intrauterine growth retardation, asphyxia, low birth weight, drug withdrawal symptoms after delivery, and behavioral, psychiatric, and learning disabilities later in life. A majority of studies cite a modified version of the Finnegan NAS scoring system or the use of administrative coding data as the preferred method to define NAS. Agreement on 90% of the scored elements is acceptable between raters using the original Finnegan NAS scoring system [18] and achievement of this benchmark requires and relies on proper provider training and education. However, given the targeted scope of this literature review—identifying specific criteria used to define NAS—the presence of a non-NAS or other pertinent comparison group was specified as inclusion criteria essential to this primary research question. ";s:7:"keyword";s:39:"neonatal abstinence syndrome definition";s:5:"links";s:1164:"Snoopy's Brother Spike Movie, Charred In A Sentence, Baju Bahan Katun, Little Miss Momma Autism, Who Plays Joe Hills Mother On Blue Bloods, Your Honor Reddit, Black Stylish Name, Olay Day Cream, Roger Debolt Boise, Samsung Thunders Vs Et Land Elephants Predictions, ";s:7:"expired";i:-1;}